Norton Rose Fulbright advises Optimi Health on equity facility | Canada | Global law firm - Norton Rose Fulbright
·Aug 13, 2026
Source: Norton Rose Fulbright
Read the original article This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
This article is an excerpt. To read the full content, visit the original source. Norton Rose Fulbright
Reactions
Related articles
Optimi Health to Present at the ThinkEquity Conference - The Globe and Mail
The Globe and Mail·
Norton Rose Fulbright adds sports-focused private equity partner - Norton Rose Fulbright
Norton Rose Fulbright·
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Medical Xpress·
0 comments
No comments yet. Be the first to share your thoughts!